CDK4/6 Inhibitors in Melanoma: A Comprehensive Review

Historically, metastatic melanoma was considered a highly lethal disease. However, recent advances in drug development have allowed a significative improvement in prognosis. In particular, BRAF/MEK inhibitors and anti-PD1 antibodies have completely revolutionized the management of this disease. None...

Full description

Saved in:
Bibliographic Details
Published in:Cells
Main Authors: Garutti, Mattia, Targato, Giada, Buriolla, Silvia, Palmero, Lorenza, Minisini, Alessandro Marco, Puglisi, Fabio
Format: Artigo
Language:Inglês
Published: MDPI 2021
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8227121/
https://ncbi.nlm.nih.gov/pubmed/34071228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10061334
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items